Market Overview

Revance Therapeutics (NASDAQ: RVNC)

12.97 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2020
After-Hours
EPS:
REV:




Q1 2020
After-Hours
EPS:
REV:
-0.85
278K



Q4 2019
After-Hours
EPS:
REV:
-1.12
487K



Q3 2019
After-Hours
EPS:
REV:
-0.91
2.362M



Q2 2019
After-Hours
EPS:
REV:
-0.94
686K
-0.91
710K
-0.86
0
5.49%
-100%
Q1 2019
After-Hours
EPS:
REV:
-0.97
193K
-0.87
1.14M
-0.85
278K
2.3%
-75.61%
Q4 2018
After-Hours
EPS:
REV:
-1.04
37K
-0.94
1.3M
-1.12
487K
19.15%
-62.54%
Q3 2018
After-Hours
EPS:
REV:
-1.01
75K
-0.97
370K
-0.91
2.362M
-6.19%
538.38%
Q2 2018
After-Hours
EPS:
REV:
-0.90
75K
-0.94
510K
-0.94
686K

34.51%
Q1 2018
After-Hours
EPS:
REV:
-0.94
75K
-0.71
5.07M
-0.97
193K
36.62%
-96.19%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!